BlackRock’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53B | Sell |
|
|||||
|
2025
Q1 | $1.68B | Buy |
|
|||||
|
2024
Q4 | $1.89B | Buy |
|
|||||
|
2024
Q3 | $1.91B | Sell |
|
|||||
|
2024
Q2 | $1.74B | Sell |
|
|||||
|
2024
Q1 | $1.28B | Buy |
|
|||||
|
2023
Q4 | $1.16B | Buy |
|
|||||
|
2023
Q3 | $1.15B | Buy |
|
|||||
|
2023
Q2 | $1.13B | Buy |
|
|||||
|
2023
Q1 | $1.06B | Buy |
|
|||||
|
2022
Q4 | $1.25B | Buy |
|
|||||
|
2022
Q3 | $906M | Buy |
|
|||||
|
2022
Q2 | $1.02B | Buy |
|
|||||
|
2022
Q1 | $767M | Buy |
|
|||||
|
2021
Q4 | $916M | Sell |
|
|||||
|
2021
Q3 | $795M | Sell |
|
|||||
|
2021
Q2 | $777M | Sell |
|
|||||
|
2021
Q1 | $738M | Buy |
|
|||||
|
2020
Q4 | $649M | Sell |
|
|||||
|
2020
Q3 | $435M | Sell |
|
|||||
|
2020
Q2 | $547M | Buy |
|
|||||
|
2020
Q1 | $423M | Sell |
|
|||||
|
2019
Q4 | $409M | Buy |
|
|||||
|
2019
Q3 | $353M | Sell |
|
|||||
|
2019
Q2 | $351M | Sell |
|
|||||
|
2019
Q1 | $586M | Buy |
|
|||||
|
2018
Q4 | $538M | Buy |
|
|||||
|
2018
Q3 | $630M | Sell |
|
|||||
|
2018
Q2 | $569M | Buy |
|
|||||
|
2018
Q1 | $552M | Buy |
|
|||||
|
2017
Q4 | $706M | Sell |
|
|||||
|
2017
Q3 | $563M | Sell |
|
|||||
|
2017
Q2 | $635M | Buy |
|
|||||
|
2017
Q1 | $642M | Buy |
|
|||||
|
2016
Q4 | $15.7M | Sell |
|
|||||
|
2016
Q3 | $14.8M | Sell |
|
|||||
|
2016
Q2 | $13.7M | Sell |
|
|||||
|
2016
Q1 | $16.8M | Sell |
|
|||||
|
2015
Q4 | $30.1M | Buy |
|
|||||
|
2015
Q3 | $15.7M | Buy |
|
|||||
|
2015
Q2 | $19.5M | Sell |
|
|||||
|
2015
Q1 | $35.5M | Buy |
|
|||||
|
2014
Q4 | $24.8M | Buy |
|
|||||
|
2014
Q3 | $19M | Sell |
|
|||||
|
2014
Q2 | $17.7M | Sell |
|
|||||
|
2014
Q1 | $22.7M | Buy |
|
|||||
|
2013
Q4 | $26.7M | Buy |
|
|||||
|
2013
Q3 | $11.8M | Buy |
|
|||||
|
2013
Q2 | $9.2M | Buy |
|